|
ETAA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.443000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.560300E-02 |
| Normal-vs-Stage2 |
3.418600E-01 |
| Normal-vs-Stage3 |
9.569600E-01 |
| Normal-vs-Stage4 |
1.474030E-01 |
| Stage1-vs-Stage2 |
9.674600E-01 |
| Stage1-vs-Stage3 |
9.061900E-02 |
| Stage1-vs-Stage4 |
2.565000E-04 |
| Stage2-vs-Stage3 |
3.682200E-01 |
| Stage2-vs-Stage4 |
1.057620E-01 |
| Stage3-vs-Stage4 |
1.770240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.252000E-01 |
| Normal-vs-AfricanAmerican |
9.259000E-01 |
| Normal-vs-Asian |
7.281000E-01 |
| Caucasian-vs-AfricanAmerican |
3.994600E-01 |
| Caucasian-vs-Asian |
8.684000E-01 |
| AfricanAmerican-vs-Asian |
8.106600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.921600E-01 |
| Normal-vs-Female |
4.625600E-02 |
| Male-vs-Female |
5.224100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.435400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.668990E-01 |
| Normal-vs-Age(61-80Yrs) |
3.392600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.290400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.730560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.218800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.690800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.412400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.773400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.583600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.697800E-03 |
| Normal-vs-Grade 2 |
4.596600E-03 |
| Normal-vs-Grade 3 |
9.367800E-01 |
| Normal-vs-Grade 4 |
2.800100E-03 |
| Grade 1-vs-Grade 2 |
3.985400E-01 |
| Grade 1-vs-Grade 3 |
3.702200E-03 |
| Grade 1-vs-Grade 4 |
1.52280999999865E-05 |
| Grade 2-vs-Grade 3 |
8.369000E-04 |
| Grade 2-vs-Grade 4 |
1.81870000171003E-08 |
| Grade 3-vs-Grade 4 |
5.841300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.211750E-04 |
| Normal-vs-ccB subtype |
1.329620E-01 |
| ccA subtype-vs-ccB subtype |
7.92059999810135E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.101400E-01 |
| Normal-vs-N1 |
3.718400E-01 |
| N0-vs-N1 |
1.424160E-01 |
|
|
